June 2015
Volume 56, Issue 7
ARVO Annual Meeting Abstract  |   June 2015
Glucosamine trapping as measure of retinal glucose transport
Author Affiliations & Notes
  • Jefferson R Brown
    Ophthalmology, University of Utah, Salt Lake City, UT
  • Bryan W Jones
    Ophthalmology, University of Utah, Salt Lake City, UT
  • Rebecca L Pfeiffer
    Ophthalmology, University of Utah, Salt Lake City, UT
  • Robert E Marc
    Ophthalmology, University of Utah, Salt Lake City, UT
  • Footnotes
    Commercial Relationships Jefferson Brown, None; Bryan Jones, None; Rebecca Pfeiffer, None; Robert Marc, Signature Immunologics (E)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5501. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jefferson R Brown, Bryan W Jones, Rebecca L Pfeiffer, Robert E Marc; Glucosamine trapping as measure of retinal glucose transport. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5501.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Just as the small molecule agmatine (AGB) is permeant to cation channels and can provide histologic readout of integrated stimulatory drive (Marc 1999), glucosamine (GCN) is readily taken up into cells of the retina by glucose transporter (GLUT) proteins and can provide a readout of cellular glucose transport. Simultaneous whole-retina incubation of AGB and GCN in the presence of excitatory pharmacology allows for a complementary approach of measuring integrated ion flow and glucose uptake in response to excitatory drive. Importantly, this approach also preserves local tissue integrity, including the metabolic support of Muller glia, while the glucose transport of both neurons and glia can be measured simultaneously and quantitatively.

Methods: Wild type and transgenic rhodopsin P347L (cone-sparing rod degeneration) rabbit retinas were acutely isolated, incubated in GCN and AGB, and stimulated with NMDA, AMPA, kainate, or domoic acid. The retinas were then fixed in glutaraldehyde, serially sectioned, and incubated with antibodies targeting GCN, AGB, and other small molecules. Quantitative readout of GCN and AGB was obtained via silver staining and light microscopy.

Results: In the wild type retina, cells responding to the stimulus with a positive AGB signal subdivided into at least three populations: 1) a linear group, where the AGB signal scaled with the GCN signal over a large range of intensities; 2) a hyper-spiking group, where the extremely high AGB signal far outpaced the GCN signal; and 3) a GCN-negative group, where the GCN signal was negligible, yet the cells still manifested a significant AGB signal. In the mutant retina, cells maintained a robust dynamic range of AGB signal, similar to the wild type, but the range of GCN signals was vastly diminished. Cells subdivided into 2 populations: those with high AGB and those with low AGB signal, both of which had a low GCN signal.

Conclusions: Retinal neurons in the P347L rabbit model of retinal degeneration have diminished glucose transport in comparison to wild type, despite maintaining a robust ionic response to pharmacologic stimuli. Glucosamine trapping is a promising tool for histologic measurement of glucose transport, allowing for more detailed investigation into the metabolic components of neuronal disease.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.